Sirna Therapeutics, Inc. To Present At UBS Warburg Global Life Sciences Conference
SAN FRANCISCO, Sept. 18 /PRNewswire-FirstCall/ -- Sirna Therapeutics, Inc. ("Sirna") (Nasdaq: RNAI - News), a leading RNAi therapeutics company, announced today that Howard W. Robin, President and Chief Executive Officer, is scheduled to give a company presentation at the UBS Global Life Sciences Conference on Monday, September 25, 2006 at 10:00 am ET at the Grand Hyatt New York in New York City.